Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17464401 | 0.84 | ALDH1A1 (0.52) | FABP4ALDH1A1MAPTTSHRHPGD | |
| SCHEMBL5605987 | 0.83 | ALDH1A1 (0.38) | FABP4ALDH1A1MAPTTSHRHPGD | |
| SCHEMBL642553 | 0.82 | ACHE (0.40) | FABP4ALDH1A1MAPTTSHRHPGD | |
| SCHEMBL24603601 | 0.82 | L3MBTL1 (0.36) | FABP4ALDH1A1MAPTTSHRHPGD | |
| SCHEMBL24822044 | 0.81 | ALOX15 (0.40) | FABP4ALDH1A1TSHRHSD17B10ALOX15 | |
| SCHEMBL24326604 | 0.81 | CYP2C9 (0.36) | FABP4ALDH1A1MAPTTSHRHPGD | |
| SCHEMBL14274969 | 0.80 | ALDH1A1 (0.39) | FABP4ALDH1A1MAPTTSHRHPGD | |
| SCHEMBL2515529 | 0.79 | ELANE (0.37) | FABP4ALDH1A1TSHRHPGDHSD17B10 | |
| SCHEMBL29450106 | 0.79 | ELANE (0.37) | FABP4ALDH1A1TSHRHPGDHSD17B10 | |
| SCHEMBL24420974 | 0.79 | NPSR1 (0.38) | FABP4ALDH1A1MAPTTSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9732101-B2 | Bioreversible boronates for delivery of molecules into cells | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-08-15 | — | — | US | disclosed |
| US-20160024122-A1 | BIOREVERSIBLE BORONATES FOR DELIVERY OF MOLECULES INTO CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024122-A1 | BIOREVERSIBLE BORONATES FOR DELIVERY OF MOLECULES INTO CELLS | BAG6, BCAP31, PHB1 | FABP4 617/4885ALDH1A1 3874/4885MAPT 1758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.